Literature DB >> 11402004

Homogeneity of antibody responses in tuberculosis patients.

K Samanich1, J T Belisle, S Laal.   

Abstract

The goals of the present study were twofold: (i) to compare the repertoires of antigens in culture filtrates of in vitro-grown Mycobacterium tuberculosis that are recognized by antibodies from noncavitary and cavitary tuberculosis (TB) patients and (ii) to determine the extent of variation that exists between the antigen profiles recognized by individual TB patients. Lipoarabinomannan-free culture filtrate proteins of M. tuberculosis were fractionated by one-dimensional (1-D) and 2-D polyacrylamide gel electrophoresis, and the Western blots were probed with sera from non-human immunodeficiency virus (non-HIV)-infected cavitary and noncavitary TB patients and from HIV-infected, noncavitary TB patients. In contrast to earlier studies based on recombinant antigens of M. tuberculosis which suggested that antibody responses in TB patients were heterogeneous (K. Lyashchenko et al., 1998, Infect. Immun. 66:3936-3940, 1998), our studies with native culture filtrate proteins show that the antibody responses in TB patients show significant homogeneity in being directed against a well-defined subset of antigens. Thus, there is a well-defined subset of culture filtrate antigens that elicits antibodies during noncavitary and cavitary disease. In addition, another set of antigens is recognized primarily by cavitary TB patients. The mapping with individual patient sera presented here suggests that serodiagnostic tests based on the subset of antigens recognized during both noncavitary and cavitary TB will enhance the sensitivity of antibody detection in TB patients, especially in difficult-to-diagnose, smear-negative, noncavitary TB patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402004      PMCID: PMC98537          DOI: 10.1128/IAI.69.7.4600-4609.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology.

Authors:  A Verbon; G J Weverling; S Kuijper; P Speelman; H M Jansen; A H Kolk
Journal:  Am Rev Respir Dis       Date:  1993-08

2.  Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis.

Authors:  G H Bothamley; R Rudd; F Festenstein; J Ivanyi
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 3.  Development of a serological test for tuberculosis. Problems and potential.

Authors:  A Verbon
Journal:  Trop Geogr Med       Date:  1994

4.  Candidate antigens for improved serodiagnosis of tuberculosis.

Authors:  E O Bassey; D Catty; D S Kumararatne; C Raykundalia
Journal:  Tuber Lung Dis       Date:  1996-04

5.  Humoral response to Mycobacterium tuberculosis-specific antigens in African tuberculosis patients with high prevalence of human immunodeficiency virus infection.

Authors:  S Thybo; C Richter; H Wachmann; S Y Maselle; D H Mwakyusa; I Mtoni; A B Andersen
Journal:  Tuber Lung Dis       Date:  1995-04

6.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

7.  Priming to heat shock proteins in infants vaccinated against pertussis.

Authors:  G Del Giudice; A Gervaix; P Costantino; C A Wyler; C Tougne; E R de Graeff-Meeder; J van Embden; R van der Zee; L Nencioni; R Rappuoli
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

8.  The Mycobacterium leprae antigen 85 complex gene family: identification of the genes for the 85A, 85C, and related MPT51 proteins.

Authors:  T F Rinke de Wit; S Bekelie; A Osland; B Wieles; A A Janson; J E Thole
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis.

Authors:  P W Roche; N Winter; J A Triccas; C G Feng; W J Britton
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

10.  Diagnostic significance of circulating immune complexes in patients with pulmonary tuberculosis.

Authors:  V V Radhakrishnan; A Mathai; P Sundaram
Journal:  J Med Microbiol       Date:  1992-02       Impact factor: 2.472

View more
  34 in total

1.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

Review 2.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Thorax       Date:  2007-08-03       Impact factor: 9.139

3.  Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis.

Authors:  Krishna K Singh; Yuxin Dong; John T Belisle; Jeffrey Harder; Vijay K Arora; Suman Laal
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis.

Authors:  Jacqueline M Achkar; Yuxin Dong; Robert S Holzman; John Belisle; Irene S Kourbeti; Tsering Sherpa; Rany Condos; William N Rom; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2006-11

Review 5.  Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Authors:  Karen R Steingart; Nandini Dendukuri; Megan Henry; Ian Schiller; Payam Nahid; Philip C Hopewell; Andrew Ramsay; Madhukar Pai; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

6.  Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status.

Authors:  Jacqueline M Achkar; Elisabeth Jenny-Avital; Xian Yu; Susanne Burger; Eric Leibert; Patrick W Bilder; Steven C Almo; Arturo Casadevall; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2010-01-13

Review 7.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

8.  Peptides of a novel Mycobacterium tuberculosis-specific cell wall protein for immunodiagnosis of tuberculosis.

Authors:  Krishna K Singh; Naresh Sharma; Diana Vargas; Zhentong Liu; John T Belisle; Visalakshi Potharaju; Ajay Wanchu; Digambar Behera; Suman Laal
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

9.  Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.

Authors:  Gavish Kumar; Pradeep Kumar Dagur; Prashant Kumar Singh; Hari Shankar; Virendra S Yadav; Vishwa M Katoch; Bharat Bajaj; Rajesh Gupta; Utpal Sengupta; Beenu Joshi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

10.  The malate synthase of Paracoccidioides brasiliensis is a linked surface protein that behaves as an anchorless adhesin.

Authors:  Benedito Rodrigues da Silva Neto; Julhiany de Fátima da Silva; Maria José Soares Mendes-Giannini; Henrique Leonel Lenzi; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  BMC Microbiol       Date:  2009-12-24       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.